Concept to Commercialization: Combining your innovative ideas, data science, and AI for commercial breakthroughs.
Tuesday, August 20, 2024 12pm to 1pm
About this Event
U Innovation welcomes Andrew Satz, CEO and Co-founder of EQLVE, a technology company that leverages advances in computing to revolutionize the design of antibodies for biopharma. A data scientist by training, Andrew is a seasoned entrepreneur and innovator with nearly two decades of experience in applied AI. He has founded 7 technology companies across multiple industries, including biotech, where he has helped bring 3 drugs from discovery to human clinical trials.
